Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11779586 Compounds comprising tricyclic heterocyclic compounds

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 15, 2020
Date of Patent
October 10, 2023
Patent Application Number
17071543
Patent Citations
‌
US Patent 8981087 Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
‌
US Patent 8242116 Fused thiazole derivatives as kinase inhibitors
‌
US Patent 8338592 Fused thiazole derivatives as kinase inhibitors
‌
US Patent 8710054 Fused thiazole derivatives as kinase inhibitors
‌
US Patent 8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
‌
US Patent 9200007 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
‌
US Patent 9266879 Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease
‌
US Patent 9580442 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
‌
US Patent 9663487 Phosphoinositide 3-kinase inhibitors
‌
US Patent 9868749 Fused imidazole and pyrazole derivatives as modulators of TNF activity
•••
Patent Inventor Names
Alexander Richard Liam Cecil
Franck Alexandre Silva
Stephen Joseph Shuttleworth
Elisabeth Ann Bone
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11779586
Patent Primary Examiner
‌
Kortney L. Klinkel
CPC Code
‌
A61K 31/5377
‌
A61K 9/2027
‌
A61K 9/2054
‌
A61K 9/2095
‌
A61K 31/5386
‌
A61K 31/519
‌
A61K 9/2018
‌
A61P 19/02
‌
A61P 29/00
‌
A61P 35/00
•••

Find more entities like US Patent 11779586 Compounds comprising tricyclic heterocyclic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo